211 related articles for article (PubMed ID: 24643533)
21.
Nice JB; Balashova NV; Kachlany SC; Koufos E; Krueger E; Lally ET; Brown AC
Toxins (Basel); 2018 Oct; 10(10):. PubMed ID: 30322160
[TBL] [Abstract][Full Text] [Related]
22. Aggregatibacter (Actinobacillus) actimycetemcomitans leukotoxin and human periodontitis - A historic review with emphasis on JP2.
Tsai CC; Ho YP; Chou YS; Ho KY; Wu YM; Lin YC
Kaohsiung J Med Sci; 2018 Apr; 34(4):186-193. PubMed ID: 29655406
[TBL] [Abstract][Full Text] [Related]
23. Characterization of leukotoxin from a clinical strain of Actinobacillus actinomycetemcomitans.
Diaz R; Ghofaily LA; Patel J; Balashova NV; Freitas AC; Labib I; Kachlany SC
Microb Pathog; 2006 Feb; 40(2):48-55. PubMed ID: 16414241
[TBL] [Abstract][Full Text] [Related]
24. Aggregatibacter actinomycetemcomitans LtxC is required for leukotoxin activity and initial interaction between toxin and host cells.
Balashova NV; Shah C; Patel JK; Megalla S; Kachlany SC
Gene; 2009 Aug; 443(1-2):42-7. PubMed ID: 19450669
[TBL] [Abstract][Full Text] [Related]
25.
Looh SC; Soo ZMP; Wong JJ; Yam HC; Chow SK; Hwang JS
Toxins (Basel); 2022 Jan; 14(1):. PubMed ID: 35051027
[TBL] [Abstract][Full Text] [Related]
26. Aggregatibacter actinomycetemcomitans leukotoxin is post-translationally modified by addition of either saturated or hydroxylated fatty acyl chains.
Fong KP; Tang HY; Brown AC; Kieba IR; Speicher DW; Boesze-Battaglia K; Lally ET
Mol Oral Microbiol; 2011 Aug; 26(4):262-76. PubMed ID: 21729247
[TBL] [Abstract][Full Text] [Related]
27. LFA-1-targeting Leukotoxin (LtxA; Leukothera®) causes lymphoma tumor regression in a humanized mouse model and requires caspase-8 and Fas to kill malignant lymphocytes.
DiFranco KM; Johnson-Farley N; Bertino JR; Elson D; Vega BA; Belinka BA; Kachlany SC
Leuk Res; 2015 Jun; 39(6):649-56. PubMed ID: 25850729
[TBL] [Abstract][Full Text] [Related]
28. Increased leukotoxin production: Characterization of 100 base pairs within the 530 base pair leukotoxin promoter region of Aggregatibacter actinomycetemcomitans.
Sampathkumar V; Velusamy SK; Godboley D; Fine DH
Sci Rep; 2017 May; 7(1):1887. PubMed ID: 28507341
[TBL] [Abstract][Full Text] [Related]
29. Receptor-Based Peptides for Inhibition of Leukotoxin Activity.
Krueger E; Hayes S; Chang EH; Yutuc S; Brown AC
ACS Infect Dis; 2018 Jul; 4(7):1073-1081. PubMed ID: 29742342
[TBL] [Abstract][Full Text] [Related]
30. Aggregatibacter actinomycetemcomitans leukotoxin utilizes a cholesterol recognition/amino acid consensus site for membrane association.
Brown AC; Balashova NV; Epand RM; Epand RF; Bragin A; Kachlany SC; Walters MJ; Du Y; Boesze-Battaglia K; Lally ET
J Biol Chem; 2013 Aug; 288(32):23607-21. PubMed ID: 23792963
[TBL] [Abstract][Full Text] [Related]
31.
Lally ET; Boesze-Battaglia K; Dhingra A; Gomez NM; Lora J; Mitchell CH; Giannakakis A; Fahim SA; Benz R; Balashova N
Pathogens; 2020 Jan; 9(2):. PubMed ID: 31973183
[TBL] [Abstract][Full Text] [Related]
32. Leukotoxin confers beta-hemolytic activity to Actinobacillus actinomycetemcomitans.
Balashova NV; Crosby JA; Al Ghofaily L; Kachlany SC
Infect Immun; 2006 Apr; 74(4):2015-21. PubMed ID: 16552030
[TBL] [Abstract][Full Text] [Related]
33. Mlc is a transcriptional activator with a key role in integrating cyclic AMP receptor protein and integration host factor regulation of leukotoxin RNA synthesis in Aggregatibacter actinomycetemcomitans.
Childress C; Feuerbacher LA; Phillips L; Burgum A; Kolodrubetz D
J Bacteriol; 2013 May; 195(10):2284-97. PubMed ID: 23475968
[TBL] [Abstract][Full Text] [Related]
34. Epigallocatechin gallate inhibits leukotoxin release by Aggregatibacter actinomycetemcomitans by promoting association with the bacterial membrane.
Chang EH; Giaquinto P; Huang J; Balashova NV; Brown AC
Mol Oral Microbiol; 2020 Jan; 35(1):29-39. PubMed ID: 31816197
[TBL] [Abstract][Full Text] [Related]
35. Purification of secreted leukotoxin (LtxA) from Actinobacillus actinomycetemcomitans.
Kachlany SC; Fine DH; Figurski DH
Protein Expr Purif; 2002 Aug; 25(3):465-71. PubMed ID: 12182827
[TBL] [Abstract][Full Text] [Related]
36. Aggregatibacter actinomycetemcomitans leukotoxin: From mechanism to targeted anti-toxin therapeutics.
Krueger E; Brown AC
Mol Oral Microbiol; 2020 Jun; 35(3):85-105. PubMed ID: 32061022
[TBL] [Abstract][Full Text] [Related]
37. Effects of Aggregatibacter actinomycetemcomitans leukotoxin on endothelial cells.
Dietmann A; Millonig A; Combes V; Couraud PO; Kachlany SC; Grau GE
Microb Pathog; 2013; 61-62():43-50. PubMed ID: 23665198
[TBL] [Abstract][Full Text] [Related]
38. Aggregatibacter actinomycetemcomitans leukotoxin induces cytosol acidification in LFA-1 expressing immune cells.
Balashova N; Dhingra A; Boesze-Battaglia K; Lally ET
Mol Oral Microbiol; 2016 Feb; 31(1):106-14. PubMed ID: 26361372
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of LtxA toxicity by blocking cholesterol binding with peptides.
Brown AC; Koufos E; Balashova NV; Boesze-Battaglia K; Lally ET
Mol Oral Microbiol; 2016 Feb; 31(1):94-105. PubMed ID: 26352738
[TBL] [Abstract][Full Text] [Related]
40. Circulating antibodies against leukotoxin A as marker of periodontitis Grades B and C and oral infection with Aggregatibacter actinomycetemcomitans.
Damgaard C; Danielsen AK; Enevold C; Reinholdt J; Holmstrup P; Nielsen CH; Massarenti L
J Periodontol; 2021 Dec; 92(12):1795-1804. PubMed ID: 33749825
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
